Top Glove sees demand doubling when vaccines ready by year-end


Its chairman Tan Sri Lim Wee Chai said that over the long term, the glove business remained good and healthy, with the company's share price depending on the earnings and performance.

KUALA LUMPUR: While pharmaceutical companies are gaining momentum on positive COVID-19 vaccination news, Top Glove Corporation Bhd expects demand for examination gloves to double when the vaccines are ready by year-end.

Its chairman Tan Sri Lim Wee Chai said that over the long term, the glove business remained good and healthy, with the company's share price depending on the earnings and performance.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Top Glove , Demand , Covid-19 update , Lim Wee Chai

Next In Business News

ETA Group to dispose of stakes in two subsidiaries for RM22.73mil
Insas proposes disposal of up to 218 million Inari shares
Kawan Renergy posts RM2.04mil net profit in 3Q
MediAsas DRG pricing framework built on RM4.8bil in hospital billings
Astino’s FY26 net profit rises 44% on stronger export margins
Ringgit closes higher against US dollar despite fed rate hike expectations
Kinergy Advancement proposes private placement to raise up to RM79.75mil
MISC, Yinson Legacy and EPF continue talks on Yinson privatisation at RM2.35 a share
Favelle Favco secures RM88.8mil offshore crane orders
TSH Resources’ Indonesian unit fined RM42mil by forest enforcement task force

Others Also Read